308 related articles for article (PubMed ID: 35804939)
21. Multiplexed immunohistochemistry for immune cell phenotyping, quantification and spatial distribution in situ.
Vasaturo A; Galon J
Methods Enzymol; 2020; 635():51-66. PubMed ID: 32122553
[TBL] [Abstract][Full Text] [Related]
22. Advancing Understanding of Non-Small Cell Lung Cancer with Multiplexed Antibody-Based Spatial Imaging Technologies.
Gray S; Ottensmeier CH
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835491
[TBL] [Abstract][Full Text] [Related]
23. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
24. Tumor heterogeneity: preclinical models, emerging technologies, and future applications.
Proietto M; Crippa M; Damiani C; Pasquale V; Sacco E; Vanoni M; Gilardi M
Front Oncol; 2023; 13():1164535. PubMed ID: 37188201
[TBL] [Abstract][Full Text] [Related]
25. High-multiplex tissue imaging in routine pathology-are we there yet?
Einhaus J; Rochwarger A; Mattern S; Gaudillière B; Schürch CM
Virchows Arch; 2023 May; 482(5):801-812. PubMed ID: 36757500
[TBL] [Abstract][Full Text] [Related]
26. De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry.
Prade VM; Kunzke T; Feuchtinger A; Rohm M; Luber B; Lordick F; Buck A; Walch A
Mol Metab; 2020 Jun; 36():100953. PubMed ID: 32278304
[TBL] [Abstract][Full Text] [Related]
27. A 31-plex panel for high-dimensional single-cell analysis of murine preclinical models of solid tumors by imaging mass cytometry.
Glasson Y; Chépeaux LA; Dumé AS; Jay P; Pirot N; Bonnefoy N; Michaud HA
Front Immunol; 2022; 13():1011617. PubMed ID: 36741363
[TBL] [Abstract][Full Text] [Related]
28. Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence.
Tien TZ; Lee JNLW; Lim JCT; Chen XY; Thike AA; Tan PH; Yeong JPS
Histopathology; 2021 Aug; 79(2):139-159. PubMed ID: 33400265
[TBL] [Abstract][Full Text] [Related]
29. Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies.
de Vries NL; Mahfouz A; Koning F; de Miranda NFCC
Front Oncol; 2020; 10():1254. PubMed ID: 32793500
[TBL] [Abstract][Full Text] [Related]
30. Quantitative single-cell analysis of immunofluorescence protein multiplex images illustrates biomarker spatial heterogeneity within breast cancer subtypes.
Cheung AM; Wang D; Liu K; Hope T; Murray M; Ginty F; Nofech-Mozes S; Martel AL; Yaffe MJ
Breast Cancer Res; 2021 Dec; 23(1):114. PubMed ID: 34922607
[TBL] [Abstract][Full Text] [Related]
31. SpaRx: Elucidate single-cell spatial heterogeneity of drug responses for personalized treatment.
Tang Z; Liu X; Li Z; Zhang T; Yang B; Su J; Song Q
bioRxiv; 2023 Aug; ():. PubMed ID: 37577665
[TBL] [Abstract][Full Text] [Related]
32. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
Front Immunol; 2018; 9():946. PubMed ID: 29780391
[TBL] [Abstract][Full Text] [Related]
33. Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment.
Muñoz R; Girotti A; Hileeto D; Arias FJ
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771577
[TBL] [Abstract][Full Text] [Related]
34. Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma.
Roemer MGM; van de Brug T; Bosch E; Berry D; Hijmering N; Stathi P; Weijers K; Doorduijn J; Bromberg J; van de Wiel M; Ylstra B; de Jong D; Kim Y
iScience; 2023 Aug; 26(8):107331. PubMed ID: 37539043
[TBL] [Abstract][Full Text] [Related]
35. Translating the immune microenvironment of thyroid cancer into clinical practice.
Cunha LL; Ward LS
Endocr Relat Cancer; 2022 May; 29(6):R67-R83. PubMed ID: 35289765
[TBL] [Abstract][Full Text] [Related]
36. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
37. SPARTIN: a Bayesian method for the quantification and characterization of cell type interactions in spatial pathology data.
Osher N; Kang J; Krishnan S; Rao A; Baladandayuthapani V
Front Genet; 2023; 14():1175603. PubMed ID: 37274781
[No Abstract] [Full Text] [Related]
38. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
39. New-generation technologies for spatial tissue analysis, indispensable tools for deciphering intratumor heterogeneity in the development of antibody-drug conjugates and radio-immunoconjugates for cancer treatment.
Radosevic-Robin N; Kossai M; Penault-Llorca F
Transl Breast Cancer Res; 2023; 4():28. PubMed ID: 38751472
[TBL] [Abstract][Full Text] [Related]
40. Investigating Ecological Interactions in the Tumor Microenvironment using Joint Species Distribution Models for Point Patterns.
Eliason J; Rao A
bioRxiv; 2023 Nov; ():. PubMed ID: 38014073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
